Literature DB >> 34611730

Fibroblastic rheumatism: an uncommon arthritis. A case-based review.

A Pieta1, A Zioga2, A Skalkou1, A I Venetsanopoulou1, A A Drosos1, P V Voulgari3.   

Abstract

Fibroblastic rheumatism (FR) is an uncommon disease of the skin, characterized by the presence of non-tender cutaneous nodules accompanied often by other rheumatic manifestations. This condition shows male predominance, no age preference and unpredictable course, resulting frequently in permanent joint damage. A 60-year-old man came to our department with a 4-year history of multiple non-tender nodules and morning stiffness affecting mainly the upper extremities. Clinical examination revealed arthritis of the hands, confirmed by imaging tests. Laboratory exams were unremarkable. A skin nodule biopsy showed a dermal collagenous lesion with myxoid areas composed of spindle and stellate cells. Immunohistochemical staining demonstrated positivity for CD68 and negativity for CD34, S100, EMA and desmine. FR was diagnosed and the patient started methylprednisolone 16 mg/day. Hydroxychloroquine 400 mg/day and methotrexate 15 mg/weekly were further added as steroid-sparing agents with clinical benefit. Clinicians should be aware of this underreported entity, which can rapidly lead to irreversible deformities.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Arthritis; Cutaneous; Fibroblastic; Fibromatosis; Nodules; Rheumatism

Mesh:

Substances:

Year:  2021        PMID: 34611730     DOI: 10.1007/s00296-021-05004-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  29 in total

1.  Fibroblastic rheumatism: a report of 4 cases with potential therapeutic implications.

Authors:  Sara A Jurado; G K Glen Alvin; M Angelica Selim; Clare A Pipkin; Douglas Kress; Maria Jasmin J Jamora; Steven D Billings
Journal:  J Am Acad Dermatol       Date:  2011-10-07       Impact factor: 11.527

2.  Preliminary experience with low-dose methotrexate in fibroblastic rheumatism.

Authors:  O Vittecoq; O Mejjad; F da Silva; P Joly; E Thomine; P Lauret; J M Thomine; X le Loët
Journal:  Arthritis Rheum       Date:  1996-12

Review 3.  Fibroblastic rheumatism: case report and review of the literature.

Authors:  Joyce M Lee; Robert P Sundel; Marilyn G Liang
Journal:  Pediatr Dermatol       Date:  2002 Nov-Dec       Impact factor: 1.588

4.  Self-healing juvenile cutaneous mucinosis: Clinical and histopathologic findings of 9 patients: The relevance of long-term follow-up.

Authors:  Isabelle Luchsinger; Jérôme Coulombe; Franco Rongioletti; Marc Haspeslagh; Anne Dompmartin; Isabelle Melki; Rawane Dagher; Brigitte Bader-Meunier; Sylvie Fraitag; Christine Bodemer
Journal:  J Am Acad Dermatol       Date:  2017-10-21       Impact factor: 11.527

Review 5.  The arthropathy of fibroblastic rheumatism.

Authors:  E Romas; M Finlay; T Woodruff
Journal:  Arthritis Rheum       Date:  1997-01

6.  Fibroblastic rheumatism: the first case with infiltration of multinuclear giant cells and raised blood lead level.

Authors:  X W Zou; J Huo; J M Wang; J Y Yuan; Y Y Ma; Q Y Wang
Journal:  Clin Exp Dermatol       Date:  2014-12-26       Impact factor: 3.470

Review 7.  An Asian case of fibroblastic rheumatism: clinical, radiological, and histological features.

Authors:  Shohei Watanabe; Kazuo Kamada; Hiroshi Imai; Haruhiko Takeda; Masato Nose; Norikazu Murata; Hitoshi Hasegawa; Haruyasu Yamamoto
Journal:  Mod Rheumatol       Date:  2010-08       Impact factor: 3.023

8.  Fibroblastic rheumatism.

Authors:  L S Ostlere; H P Stevens; M Jarmulowicz; C Higgens; C Black; M H Rustin
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

9.  Response of fibroblastic rheumatism to infliximab.

Authors:  Ricardo Romiti; Mauricio Levy Neto; Marcello Menta Simonsen Nico
Journal:  Dermatol Res Pract       Date:  2010-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.